Pancreatogenic diabetes mellitus is most commonly the result of chronic pancreatitis but can also occur secondary to pancreatic cancer. The early identification of pancreatogenic diabetes and distinction from the more prevalent type 2 diabetes are clinically significant; however, currently, there is no validated method to differentiate these diabetes subtypes. We describe a study, "Evaluation of a Mixed Meal Test for Diagnosis and Characterization of PancrEaTogEniC DiabeTes Secondary to Pancreatic Cancer and Chronic Pancreatitis: the DETECT study," that seeks to address this knowledge gap. The DETECT study is a multicenter study that will examine differences in hormone and glucose excursions after a mixed meal test. The study will also create a biorepository that will be used to evaluate novel diagnostic biomarkers for differentiating these diabetes subtypes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195331PMC
http://dx.doi.org/10.1097/MPA.0000000000001168DOI Listing

Publication Analysis

Top Keywords

pancreatogenic diabetes
16
pancreatic cancer
16
chronic pancreatitis
16
mixed meal
12
meal test
12
secondary pancreatic
12
test diagnosis
8
diagnosis characterization
8
characterization pancreatogenic
8
diabetes
8

Similar Publications

Central pancreatectomy: An uncommon but potentially optimal choice of pancreatic resection.

Hepatobiliary Pancreat Dis Int

November 2024

Department of Academic Surgery, The Royal Marsden NHS Foundation Trust, Fulham Road, Chelsea, London SW3 6JJ, UK; Department of HPB Surgery, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol Royal Infirmary, Upper Maudlin St, Bristol BS2 8HW, UK. Electronic address:

Benign, premalignant or low-grade malignant pancreatic tumors are increasingly diagnosed owing to the widespread uptake of cross-sectional imaging. Surgical excision is a potential treatment option for these tumors. Pancreatoduodenectomy and distal pancreatectomy are the standard resections for tumors located in the pancreatic head-neck or body-tail, respectively, and not uncommonly sacrifice a significant amount of healthy pancreatic parenchyma.

View Article and Find Full Text PDF

Glycemic Variability in Pancreatogenic Diabetes Mellitus: characteristics, Risks, Potential Mechanisms, and Treatment Possibilities.

Int J Gen Med

September 2024

Department of Endocrinology, Gusu School, Nanjing Medical University, The First People's Hospital of Kunshan, Kunshan, 215300, People's Republic of China.

Article Synopsis
  • Pancreatogenic diabetes mellitus is becoming more prominent due to its high rates of occurrence, complications, and mortality, with glycemic variability (GV) being a key risk factor.
  • Effective management of GV is essential for preventing this type of diabetes and improving patient outcomes, yet many patients receive inadequate or potentially harmful medications.
  • This study aims to explore the connection between GV and pancreatogenic diabetes, investigate underlying mechanisms, and offer lifestyle tips and better medication choices for managing GV in affected patients.
View Article and Find Full Text PDF
Article Synopsis
  • * After ruling out common causes like insulin use and sepsis, other potential causes, such as nesidioblastosis (a rare form of hypoglycemia), should be investigated.
  • * A case study of a non-diabetic male with symptoms like dizziness and palpitations revealed that he had nesidioblastosis instead of insulinoma, demonstrating the importance of thorough evaluation.
View Article and Find Full Text PDF

Type 3c diabetes mellitus (T3cDM), also known as pancreatogenic or pancreoprivic diabetes, is a specific type of DM that often develops as a result of diseases affecting the exocrine pancreas, exhibiting an array of hormonal and metabolic characteristics. Several pancreatic exocrine diseases and surgical procedures may cause T3cDM. Diagnosing T3cDM remains difficult as the disease characteristics frequently overlap with clinical presentations of type 1 DM (T1DM) or type 2 DM (T2DM).

View Article and Find Full Text PDF
Article Synopsis
  • Pancreatic surgery is complex and can lead to significant complications; centralizing these services in large-volume centers has improved patient outcomes.
  • The editorial emphasizes the link between diabetes mellitus and pancreatic disease, stressing the importance of specialist diabetes teams in managing patients undergoing pancreatic surgery, particularly those with type 3c pancreatogenic diabetes.
  • Effective preoperative diabetes assessment and early intervention by diabetes experts are crucial for optimizing glycemic control and improving outcomes in patients with complex pancreatitis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!